APA (7th ed.) Citation

WM, H., FHM, M., LMG, M., CM, H., GJA, O., KMA, D., & LAA, B. (2020). Assessment of ARX expression, a novel biomarker for metastatic risk in pancreatic neuroendocrine tumors, in endoscopic ultrasound fine-needle aspiration. Diagnostic cytopathology, 48(4), 308. https://doi.org/10.1002/dc.24368

Chicago Style (17th ed.) Citation

WM, Hackeng, Morsink FHM, Moons LMG, Heaphy CM, Offerhaus GJA, Dreijerink KMA, and Brosens LAA. "Assessment of ARX Expression, a Novel Biomarker for Metastatic Risk in Pancreatic Neuroendocrine Tumors, in Endoscopic Ultrasound Fine-needle Aspiration." Diagnostic Cytopathology 48, no. 4 (2020): 308. https://doi.org/10.1002/dc.24368.

MLA (9th ed.) Citation

WM, Hackeng, et al. "Assessment of ARX Expression, a Novel Biomarker for Metastatic Risk in Pancreatic Neuroendocrine Tumors, in Endoscopic Ultrasound Fine-needle Aspiration." Diagnostic Cytopathology, vol. 48, no. 4, 2020, p. 308, https://doi.org/10.1002/dc.24368.